DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin

European Journal of Biochemistry

Volumn 266, Issue 2, 1999, Pages 392-402

  Loskotová, Hana ^a   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Cross links; Distamycin; DNA; Minor groove; Platinum drugs

Indexed keywords

CISPLATIN; DISTAMYCIN A; DNA; ETHIDIUM BROMIDE; FLUORESCENT DYE; PLATINUM; TERBIUM; TRANSPLATIN; ANTINEOPLASTIC AGENT; CROSS LINKING REAGENT; DNA BINDING PROTEIN; ETHIDIUM; INTERCALATING AGENT; PEPTIDE;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BASE PAIRING; CIRCULAR DICHROISM; DIFFERENTIAL PULSE POLAROGRAPHY; DNA ADDUCT; DNA CROSS LINKING; DNA DENATURATION; DNA MODIFICATION; DRUG DNA BINDING; DRUG DNA INTERACTION; GEL ELECTROPHORESIS; PRIORITY JOURNAL; CELL FREE SYSTEM; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DNA SUPERCOILING; GENETIC TRANSCRIPTION; METABOLISM; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; TIME; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL-FREE SYSTEM; CIRCULAR DICHROISM; CISPLATIN; CROSS-LINKING REAGENTS; DISTAMYCINS; DNA; DNA ADDUCTS; DNA, SUPERHELICAL; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ETHIDIUM; INTERCALATING AGENTS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; PEPTIDES; PROTEIN BINDING; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033485707     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00866.x     Document Type: Article

References (59)

1. 1. Johnson, N.P., Butour, J.-L., Villani, G., Wimmer, F.L., Defais, M., Pierson, V. & Brabec, V. (1989) Metal anti-tumor compounds: the mechanism of action of platinum complexes. Prog. Clin. Biochem. Med. 10, 1-24.
2. 2. Eastman, A. (1987) The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther. 34, 155-166.
3. 3. Fichtinger-Schepman, A.M.J., Van der Veer, J.L., Den Hartog, J.H.J., Lohman, P.H.M. & Reedijk, J. (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum (II) with DNA: formation, identification, and quantitation. Biochemistry 24, 707-713.
4. 4. Sundquist, W.I. & Lippard, S.J. (1990) The coordination chemistry of platinum anticancer drugs and related compounds with DNA. Coord. Chem. Rev. 100, 293-322.
5. 5. Leng, M. & Brabec, V. (1994) DNA adducts of cisplatin, transplatin and platinum-intercalating drugs. In DNA Adducts: Identification and Biological Significance (Hemminki, K., Dipple, A., Shuker, D.E.G., Kadlubar, F.F., Segerbäck, D. & Bartsch, H., eds), pp. 339-348. International Agency for Research on Cancer, Lyon.
6. 6. Broggini, M., Erba, E., Ponti, M., Ballinari, D., Geroni, C., Spreafico, F. & D'Inlaci, M. (1991) Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res. 51, 199-204.
7. 32P-end-labeled DNA. Biochemistry 29, 6827-6838.
8. 8. Zimmer, C. (1975) Effects of the antibiotics netropsin and distamycin A on the structure and function of nucleic acids. Prog. Nucleic Acids Res. Mol. Biol. 15, 285-318.
9. 9. Zimmer, C. & Wahnert, U. (1986) Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Prog. Biophys. Mol. Biol. 47, 31-112.
10. 10. Lee, M., Simpson, J.E., Burns, A.J., Kupchinsky, S., Brooks, N., Hartley, J.A. & Kelland, L.R. (1996) Novel platinum (II) derivatives of analogues of netropsin and distamycin: synthesis, DNA binding and cytotoxic properties. Med. Chem. Res. 6, 365-371.
11. 11. Brabec, V. & Paleček, E. (1970) The influence of salts and pH on polarographic currents produced by denatured DNA. Biophysik 6, 290-300.
12. 12. Brabec, V. & Paleček, E. (1976) Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides. Biophys. Chem. 4, 76-92.
13. 13. Lemaire, M.A., Schwartz, A., Rahmouni, A.R. & Leng, M. (1991) Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. Proc. Natl Acad. Sci. USA 88, 1982-1985.
14. 14. Kim, S.D., Vrána, O., Kleinwächter, V., Niki, K. & Brabec, V. (1990) Polarographic determination of subnanogram quantities of free platinum in reaction mixture with DNA. Anal. Lett. 23, 1505-1518.
15. 15. Brabec, V. & Leng, M. (1993) DNA interstrand cross-links of transdiamminedichloroplatinum (II) are preferentially formed between guanine and complementary cytosine residues. Proc. Natl Acad. Sci. USA 90, 5345-5349.
16. 16. Keck, M.V. & Lippard, S.J. (1992) Unwinding of supercoiled DNA by platinum ethidium and related complexes. J. Am. Chem. Soc. 114, 3386-3390.
17. 17. Farrell, N., Qu, Y., Feng, L. & Van Houten, B. (1990) Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis (platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. Biochemistry 29, 9522-9531.
18. 18. Topal, M.D. & Fresco, J.R. (1980) Fluorescence of terbium ion-nucleic acid complexes: a sensitive specific probe for unpaired residues in nucleic acids. Biochemistry 19, 5531-5537.
19. 19. Balcarová, Z. & Brabec, V. (1989) Reinterpretation of fluorescence of terbium ion-DNA complexes. Biophys. Chem. 33, 55-61.
20. 20. Butour, J.L. & Macquet, J.P. (1977) Differentiation of DNA-platinum complexes by fluorescence. The use of an intercalating dye as a probe. Eur. J. Biochem. 78, 455-463.
21. 2]. Eur. J. Biochem. 202, 975-980.
22. 22. Bancroft, D.P., Lepre, C.A. & Lippard, S.J. (1990) Pt-195 NMR kinetic and mechanistic studies of cis-diamminedichloroplatinum and transdiamminedichloroplatinum (II) binding to DNA. J. Am. Chem. Soc. 112, 6860-6871.
23. 23. Brabec, V., Boudný, V. & Balcarová, Z. (1994) Monofunctional adducts of platinum (II) produce in DNA a sequence-dependent local denaturation. Biochemistry 32, 1316-1322.
24. 24. Nováková, O., Vrána, O., Kiseleva, V.I. & Brabec, V. (1995) DNA interactions of antitumor platinum (IV) complexes. Eur. J. Biochem. 228, 616-624.
25. 3)(quinoline)]. Eur. J. Biochem. 254, 547-557.
26. 2]. Nucleic Acids Res. 24, 336-341.
27. 27. Luck, G., Zimmer, C., Reinert, K.-E. & Arcamone, F. (1977) Specific interactions of distamycin A and its analogs with (A.T) rich and (G.C) rich duplex regions of DNA and deoxypolynucleotides. Nucleic Acids Res. 4, 2655-2670.
28. 28. Zimmer, C. & Luck, G. (1992) Use of circular dichroism to probe DNA structure and drug binding to DNA. Adv. DNA Sequence Specific Agents 1, 51-88.
29. 29. Chen, F.M. & Sha, F. (1998) Circular dichroic and kinetic differentiation of DNA binding modes of distamycin. Biochemistry 37, 11143-11151.
30. 30. Brabec, V., Kleinwächter, V., Butour, J.L. & Johnson, N.P. (1990) Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. Biophys. Chem. 35, 129-141.
31. 31. Kopka, M.L., Yoon, C., Goodsell, D., Pjura, P. & Dickerson, R. (1985) The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc. Natl Acad. Sci. USA 82, 1376-1380.
32. 32. Waring, M. (1987) Dynamic aspects of antibiotic-DNA interaction. In DNA-Ligand Interactions. From Drugs to Proteins (Guschlbauer, W. & Saenger, W., eds), pp. 113-126. Plenum Press, NATO ASI Series, New York.
33. 33. Vrána, O., Boudný, V. & Brabec, V. (1996) Superhelical torsion controls DNA interstrand cross-linking by anti-tumor cis-diamminedichloroplatinum (II). Nucleic Acids Res. 24, 3918-3925.
34. 34. Bellon, S.F., Coleman, J.H. & Lippard, S.J. (1991) DNA unwinding produced by site-specific intrastrand cross-links of the anti-tumor drug cis-diamminedichloroplatinum (II). Biochemistry 30, 8026-8035.
35. 35. Yang, D.Z., Vanboom, S.S.G.E., Reedijk, J., Van Boom, J.H. & Wang, A.H.J. (1995) Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis. Biochemistry 34, 12912-12920.
36. 36. Gelasco, A. & Lippard, S.J. (1998) NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum (II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Biochemistry 37, 9230-9239.
37. 37. Huang, H.F., Zhu, L.M., Reid, B.R., Drobny, G.P. & Hopkins, P.B. (1995) Solution structure of a cisplatin-induced DNA interstrand cross-link. Science 270, 1842-1845.
38. 38. Paquet, F., Perez, C., Leng, M., Lancelot, G. & Malinge, J.M. (1996) NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug cis-diamminedichloroplatinum (II). J. Biomol. Struct. Dynamics 14, 67-77.
39. 39. Malinge, J.M., Perez, C. & Leng, M. (1994) Base sequence-independent distorsions induced by interstrand cross-links in cis-diaminedichloroplatinum (II)-modified DNA. Nucleic Acids Res. 22, 3834-3839.
40. 40. Coste, F., Malinge, J.-M., Serre, L., Shepard, W., Roth, M., Leng, M. & Zelwer, C. (1999) Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 Å resolution: hydration at the platinated site. Nucleic Acids Res. 27, 1837-1846.
41. 41. Kane, S.A. & Lippard, S.J. (1996) Photoreactivity of platinum (II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Biochemistry 35, 2180-2188.
42. 42. Sinden, R.R. (1994). DNA Structure and Function. Academic Press, San Diego, CA.
43. 43. Vrána, O., Brabec, V. & Kleinwächter, V. (1986) Polarographic studies on the conformation of some platinum complexes: relations to anti-tumour activity. Anti-Cancer Drug Design 1, 95-109.
44. 44. Žaludová, R., Kleinwächter, V. & Brabec, V. (1996) The effect of ionic strength on melting of DNA modified by platinum (II) complexes. Biophys. Chem. 60, 135-142.
45. 45. Arquilla, M., Thompson, L.M., Pearlman, L.F. & Simpkins, H. (1983) Effect of platinum antitumor agents on DNA and RNA investigated by terbium fluorescence. Cancer Res. 43, 1211-1216.
46. 46. Hoeschele, J.D., Kraker, A.J., Qu, Y., Van Houten, B. & Farrell, N. (1990) Bis (platinum) complexes, chemistry, antitumor activity and DNA-binding. In Molecular Basis of Specificity in Nucleic Acid-Drug Interactions (Pullman, B. & Jortner, J., eds), pp. 301-321. Academic Press, Dordrecht, The Netherlands.
47. 47. Farrell, N. (1991) Structurally novel platinum antitumor compounds. In Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (Howell, S.B., ed.), pp. 81-91. Plenum Press, New York.
48. 48. Zhen, W.P., Link, C.J., O'Connor, P.M., Reed, E., Parker, R., Howell, S.B. & Bohr, V.A. (1992) Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol. Cell. Biol. 12, 3689-3698.
49. 49. Larminat, F., Zhen, W. & Bohr, V.A. (1993) Gene-specific DNA repair of interstrand cross-links induced by chemotherapeutic agents can be preferential. J. Biol. Chem. 268, 2649-2654.
50. 3, pyridine). Biochemistry 32, 9632-9638.
51. 51. Johnson, S.W., Perez, R.P., Godwin, A.K., Yeung, A.T., Handel, L.M., Ozols, R.F. & Hamilton, T.C. (1994) Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem. Pharmacol. 47, 689-697.
52. 52. Larminat, F. & Bohr, V.A. (1994) Role of the human ERCC-I gene in gene-specific repair of cisplatin-induced DNA damage. Nucleic Acids Res. 22, 3005-3010.
53. 53. Stanzione, S., Cimoli, G., Debernardis, D., Michelotti, A., Conte, P.F., Parodi, S. & Russo, P. (1995) Interferon-alpha or beta potentiate platinum analogous in human glioblastoma cell lines. Mutation Res. Lett. 348, 131-135.
54. 54. Yang, L.Y., Li, L., Keating, M.J. & Plunkett, W. (1995) Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair. Mol. Pharmacol. 47, 1072-1079.
55. 55. Li, L., Keating, M.J., Plunkett, W. & Yang, L.Y. (1997) Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance. Mol. Pharmacol. 52, 798-806.
56. 56. Li, L., Liu, X.M., Glassman, A.B., Keating, M.J., Stros, M., Plunkett, W. & Yang, L.Y. (1997) Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res. 57, 1487-1494.
57. 57. Žaludová, R., Žákovská, A., Kašpárková, J., Balcarová, Z., Kleinwächter, V., Vrána, O., Farrell, N. & Brabec, V. (1997) DNA interactions of bifunctional dinuclear platinum (II) antitumor agents. Eur. J. Biochem. 246, 508-517.
58. 58. Wegner, M. & Grummt, F. (1990) Netropsin, distamycin and berenil interact differentially with a high-affinity binding site for the high mobility group protein HMG-I. Biochem. Biophys. Res. Commun. 166, 1110-1117.
59. 59. Zamble, D.B. & Lippard, S.J. (1999) The response of cellular proteins to cisplatin-damaged DNA. In Cisplatin, Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B., ed.), pp. 73-110. VHCA, Wiley-VCH, Zürich.